Literature DB >> 11550054

Anxiolytic activity of endogenous nootropic dipeptide cycloprolylglycine in elevated plus-maze test.

T A Gudasheva1, M A Konstantinopol'skii, R U Ostrovskaya, S B Seredenin.   

Abstract

Testing in an elevated plus-maze revealed dose-dependent anxiolytic activity of piracetam analog cycloprolylglycine. Intraperitoneal injection of this agent (0.05 mg/kg) 9-fold prolonged the time spent in open arms compared to the control, without affecting the total motor activity. This effect was stereo-selective: D-enantiomer in doses of 0.05 and 0.1 mg/kg was inactive. Therefore, cycloprolylglycine is similar to piracetam in not only nootropic, but also anxiolytic activity. The existence of an endogenous system responsible for the co-regulation of memory and anxiety is hypothesized.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11550054     DOI: 10.1023/a:1017928116025

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

1.  A New Component in the Mechanism of Regulation of Endogenous Depressive-Like States.

Authors:  T L Garibova; T A Gudasheva; S B Seredenin
Journal:  Dokl Biochem Biophys       Date:  2019-11-25       Impact factor: 0.788

2.  Preclinical Pharmacokinetics of GZK-111, a Dipeptide with Neuroprotective Activity.

Authors:  A A Litvin; G B Kolyvanov; P O Bochkov; R V Shevchenko; A L Podol'ko; K N Kolyasnikova; V P Zherdev
Journal:  Bull Exp Biol Med       Date:  2022-01-10       Impact factor: 0.804

3.  Effects of glyprolines on stress-induced behavioral disorders in rats.

Authors:  S E Badmaeva; G N Kopylova; N N Abushinova; G E Samonina; B A Umarova
Journal:  Neurosci Behav Physiol       Date:  2006-05

4.  Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport.

Authors:  Richard J Naftalin; Philip Cunningham; Iram Afzal-Ahmed
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.